Premium
The Future of Drug Safety
Author(s) -
Breckenridge A
Publication year - 2007
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.6100079
Subject(s) - drug , medicine , pharmacology , intensive care medicine
To provide a European perspective, I was invited to sit on the Institute of Medicine (IOM) committee that was charged with assessing the current system for evaluating and ensuring postmarketing drug safety in the United States. My colleagues on the committee came from a variety of professional backgrounds (health care, epidemiology, law, and economics), and the committee was managed by an experienced IOM staff member. 1 Clinical Pharmacology & Therapeutics (2007) 81 , 161–163. doi: 10.1038/sj.clpt.6100079